Hydrodynamic flash nanoprecipitation process for encapsulating organic and inorganic agents within composite nanoparticles

Background

The fields of nanotechnology and nanomedicine are rapidly advancing, particularly concerning targeted drug delivery and biomedical imaging. There is a critical need to develop stable, biocompatible carriers capable of operating effectively within in vivo environments. Modern medical applications increasingly demand multifunctional platforms that can simultaneously transport therapeutic agents and diagnostic imaging tools directly to specific biological sites. To achieve this, researchers need reliable methods to integrate both hydrophobic pharmaceutical compounds and inorganic nanoparticles, like quantum dots or superparamagnetic metals, into a single delivery vehicle that can safely navigate physiological fluids without triggering adverse responses.

Despite this clear need, current approaches face significant limitations. Traditional carriers, such as liposomes, polymeric vesicles, and micelles, struggle to efficiently integrate both hydrophobic drugs and inorganic nanostructures due to severe aggregation and solubility issues. Furthermore, bare inorganic nanoparticles are inherently incompatible with biological fluids because of their high hydrophobicity and potential toxicity. While conventional encapsulation strategies like solvent evaporation and emulsification exist, they are fundamentally flawed. These traditional techniques typically suffer from exceedingly low loading capacities, poor control over final composition, and highly non-uniform particle sizes, while also requiring extensive, time-consuming purification steps.

Technology

The hydrodynamic flash nanoprecipitation process is a tunable manufacturing solution that produces composite nanoparticles encapsulating hydrophobic organic compounds and inorganic nanostructures. The method utilizes intense micromixing within a multi-inlet vortex or confined impinging jet mixer. By rapidly combining an organic solvent—containing the active agents and an amphiphilic polymer—with an aqueous anti-solvent, the system induces rapid supersaturation and precipitation. This yields uniformly sized nanoparticles featuring a hydrophobic core and a hydrophilic polymeric shell. Operators can precisely control particle size and loading capacity by adjusting flow rates, while the shell can be functionalized for site-specific delivery.

This technology is highly differentiated because it overcomes the limitations of traditional methods like solvent evaporation, which typically suffer from low loading capacities and non-uniform sizes. By eliminating the need for surfactants and extensive purification, the process achieves high yields and encapsulation efficiencies exceeding 99.5%. Furthermore, it provides independent control over nanoparticle size and component ratios. The resulting nanoparticles exhibit superior stability and resist flocculation in physiological environments. Ultimately, this scalable platform uniquely enables the creation of multifunctional, biocompatible carriers that seamlessly integrate therapeutic and diagnostic agents into a single targeted delivery system.

Benefits

• Enables the simultaneous encapsulation of both hydrophobic drugs and inorganic imaging agents, creating multifunctional nanoparticles for combined therapeutic and diagnostic (theranostic) applications.
• Provides precise, independent control over nanoparticle size (1 to 1000 nm) and active agent loading capacity through easily tunable process parameters.
• Produces highly stable, biocompatible nanoparticles with a hydrophilic polymeric shell that prevents aggregation and flocculation in aqueous and physiological environments.
• Achieves exceptionally high encapsulation efficiency (e.g., >99.5%) and high loading capacities without requiring surfactants or extensive purification steps.
• Allows for easy surface functionalization of the outer polymeric shell with targeting agents to facilitate site-specific delivery and controlled release.
• Offers a robust, rapid, and scalable manufacturing platform that overcomes the low yield and non-uniformity limitations of traditional nanoparticle synthesis methods.

Applications

• Targeted hydrophobic drug delivery
• Theranostic nanoparticle manufacturing
• Medical imaging contrast agents
• Controlled release pharmaceutical formulations
• Fluorescent dye encapsulation

Additional info

This hydrodynamic flash nanoprecipitation method employs high-shear micromixing (Reynolds number >1600) to induce rapid supersaturation. It encapsulates hydrophobic organic compounds and inorganic nanostructures within amphiphilic polymeric carriers. The resulting composite nanoparticles (1–1000 nm) feature a hydrophobic core and a hydrophilic shell, providing steric stabilization in aqueous media. This process allows for precise, independent control over particle size and loading for targeted delivery and imaging.